You are the news now

THE NEWS COMMENTER

VOTE  (0)  (0)

Moderna hails diversity of Covid trial participants

Added 10-22-20 02:04:03pm EST - “Biotech firm Moderna said Thursday that it had successfully recruited ethnic minorities, older people and those with underlying health issues for its Covid-19 vaccines trial, after it pushed to enrol groups most vulnerable to the…” - News.yahoo.com

CLICK TO SHARE

Posted By TheNewsCommenter: From News.yahoo.com: “Moderna hails diversity of Covid trial participants”. Below is an excerpt from the article.

Biotech firm Moderna said Thursday that it had successfully recruited ethnic minorities, older people and those with underlying health issues for its Covid-19 vaccines trial, after it pushed to enrol groups most vulnerable to the virus.

Moderna said it had now signed up all 30,000 participants for the phase-3 trial, and more than 25,000 of them had already received a second dose of the vaccine, four weeks after the first.

The firm said it was working "to develop a vaccine for everyone, including communities that have historically been under-represented in clinical research and are disproportionately impacted by Covid-19."

More than 7,000 people taking part in the trial are over 65, and more than 5,000 under 65 have high-risk diseases such as diabetes, severe obesity and cardiac disease.

The firm said more than 11,000 are "from communities of color, representing 37 percent of the study population and similar to the diversity of the US at large" -- 6,000 are Hispanic or Latino, and more than 3,000 are African-American.

Read more...

If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

CLICK TO SHARE

BACK TO THE HOME-PAGE